VERISMO THERAPEUTICS
Live / Applied — Statement of use — processing complete, to examiner (as of 09 Mar 2026)
What this means for you
Not registered yet, but its 11 Jul 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98079556
- Mark type
- Stylized text
- Filed
- 11 Jul 2023
- Published for opposition
- 25 Mar 2025
- Attorney of record
- Christopher D. Olszyk, Jr.
Goods and services
- Class 005 — Pharmaceuticals: anti-cancer preparations; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer for use in Chimeric Antigen Receptor (CAR) T-Cell Therapy; pharmaceutical preparations for the suppression and treatment of tumors
Owner
- Verismo Therapeutics Inc., Philadelphia, PA, US
- Verismo Therapeutics Inc., Philadelphia, PA, US
Prosecution history
- 09 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Sept 2025 — USE AMENDMENT FILED
- 09 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 20 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Mar 2025 — PUBLISHED FOR OPPOSITION
- 19 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Jan 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 29 Oct 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 29 Oct 2024 — FINAL REFUSAL E-MAILED
- 29 Oct 2024 — FINAL REFUSAL WRITTEN